Coronavirus: Oman approves Pfizer-BioNTech COVID-19 vaccine for emergency use

Published: Updated:

Oman's health ministry has issued a licence to import the vaccine developed by Pfizer and BioNTech against the novel coronavirus, the sultanate's state-run TV channel said on Tuesday.

Earlier this month, Oman confirmed it will exempt nationals of 103 counties from needing an entry visa for a stay of up to 10 days, in a move to support tourism and shore up its struggling economy.

Visitors must have a confirmed hotel reservation, health insurance and a return ticket, Royal Oman Police said on its Twitter account.

The Gulf state resumed international flights on October 1, but only citizens and people holding valid existing residency and work visas could enter.

Oman, rated sub-investment grade by all major credit rating agencies, faces a widening deficit and large debt maturities in coming few years. It has recently embarked on a new fiscal plan to wean itself off its dependence on oil revenues.

Read the latest updates in our dedicated coronavirus section.

Read more:

Saudi Arabia opens COVID-19 vaccine registration via Sehhaty app

US FDA raises no new concerns with Moderna’s COVID-19 vaccine

Lebanon to sign with Pfizer for COVID-19 vaccine, first batch in two months: Minister

Top Content Trending